This is an old revision of this page, as edited by C6541 (talk | contribs) at 22:05, 27 November 2012 (added Category:Dopamine reuptake inhibitors using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 22:05, 27 November 2012 by C6541 (talk | contribs) (added Category:Dopamine reuptake inhibitors using HotCat)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
Other names | 4-Fluoromeperidine, 4-Fluoropethidine |
ATC code |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H20FNO2 |
Molar mass | 265.322 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
4-Fluoropethidine is a drug that is a derivative of pethidine (meperidine), which combines pethidine's opioid analgesic effects with increased monoamine reuptake inhibition. It is around 50% less potent than pethidine as an opioid analgesic, but conversely is 50% more potent as a dopamine reuptake inhibitor, with other derivatives such as the 4-iodo and 3,4-dichloro analogues being even more potent dopamine reuptake inhibitors again. However none of these compounds substitute for cocaine or produce stimulant effects in animals, suggesting that they still act primarily as opioid analgesic drugs in practice.
See also
References
- Lomenzo SA, Rhoden JB, Izenwasser S, Wade D, Kopajtic T, Katz JL, Trudell ML (2005). "Synthesis and biological evaluation of meperidine analogues at monoamine transporters". Journal of Medicinal Chemistry. 48 (5): 1336–43. doi:10.1021/jm0401614. PMID 15743177.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)
This analgesic-related article is a stub. You can help Misplaced Pages by expanding it. |